Recurrent rhinovirus infections in a child with inherited MDA5 deficiency.

Lamborn I,Jing H,Zhang Y,Drutman S,Abbott J,Munir S,Bade S,Murdock H,Santos C,Brock L,Masutani E,Fordjour E,McElwee J,Hughes J,Nichols D,Belkadi A,Oler A,Happel C,Matthews H,Abel L,Collins P,Subbarao K,Gelfand E,Ciancanelli M,Casanova J,Su H

Source :

J. Exp. Med.

2017 Jun 12

Pmid / DOI:

28606988

Abstract

MDA5 is a cytosolic sensor of double-stranded RNA (ds)RNA including viral byproducts and intermediates. We studied a child with life-threatening, recurrent respiratory tract infections, caused by viruses including human rhinovirus (HRV), influenza virus, and respiratory syncytial virus (RSV). We identified in her a homozygous missense mutation in that encodes MDA5. Mutant MDA5 was expressed but did not recognize the synthetic MDA5 agonist/(ds)RNA mimic polyinosinic-polycytidylic acid. When overexpressed, mutant MDA5 failed to drive luciferase activity from the promoter or promoters containing ISRE or NF-κB sequence motifs. In respiratory epithelial cells or fibroblasts, wild-type but not knockdown of MDA5 restricted HRV infection while increasing IFN-stimulated gene expression and IFN-β/λ. However, wild-type MDA5 did not restrict influenza virus or RSV replication. Moreover, nasal epithelial cells from the patient, or fibroblasts gene-edited to express mutant MDA5, showed increased replication of HRV but not influenza or RSV. Thus, human MDA5 deficiency is a novel inborn error of innate and/or intrinsic immunity that causes impaired (ds)RNA sensing, reduced IFN induction, and susceptibility to the common cold virus.This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Voir la publication

Toutes les publications